Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis
- 24 October 2002
- journal article
- Published by Wiley in Molecular Microbiology
- Vol. 46 (2), 453-466
- https://doi.org/10.1046/j.1365-2958.2002.03162.x
Abstract
The inhA and kasA genes of Mycobacterium tuberculosis have each been proposed to encode the primary target of the antibiotic isoniazid (INH). Previous studies investigating whether overexpressed inhA or kasA could confer resistance to INH yielded disparate results. In this work, multicopy plasmids expressing either inhA or kasA genes were transformed into M. smegmatis, M. bovis BCG and three different M. tuberculosis strains. The resulting transformants, as well as previously published M. tuberculosis strains with multicopy inhA or kasAB plasmids, were tested for their resistance to INH, ethionamide (ETH) or thiolactomycin (TLM). Mycobacteria containing inhA plasmids uniformly exhibited 20-fold or greater increased resistance to INH and 10-fold or greater increased resistance to ETH. In contrast, the kasA plasmid conferred no increased resistance to INH or ETH in any of the five strains, but it did confer resistance to thiolactomycin, a known KasA inhibitor. INH is known to increase the expression of kasA in INH-susceptible M. tuberculosis strains. Using molecular beacons, quantified inhA and kasA mRNA levels showed that increased inhA mRNA levels corre--lated with INH resistance, whereas kasA mRNA levels did not. In summary, analysis of strains harbouring inhA or kasA plasmids yielded the same conclusion: overexpressed inhA, but not kasA, confers INH and ETH resistance to M. smegmatis, M. bovis BCG and M. tuberculosis. Therefore, InhA is the primary target of action of INH and ETH in all three species.Keywords
This publication has 62 references indexed in Scilit:
- EthA, a Common Activator of Thiocarbamide-Containing Drugs Acting on Different Mycobacterial TargetsAntimicrobial Agents and Chemotherapy, 2007
- Crystal structure of Mycobacterium tuberculosis 6-hydroxymethyl-7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action 1 1Edited by I. WilsonJournal of Molecular Biology, 2000
- Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugsJournal of Molecular Biology, 2000
- The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3lketoacyl reductase that fails to confer isoniazid resistanceMicrobiology, 1998
- Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosisScience, 1998
- Structure and function of the dihydropteroate synthase from staphylococcus aureusJournal of Molecular Biology, 1997
- Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Binding of Catalase-Peroxidase-Activated Isoniazid to Wild-Type and Mutant Mycobacterium tuberculosis Enoyl-ACP ReductasesJournal of the American Chemical Society, 1996
- The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosisNature, 1992
- Inhibition by Isoniazid of Synthesis of Mycolic Acids in Mycobacterium tuberculosisJournal of General Microbiology, 1970